Reversibility of established diabetic glomerulopathy by anti-TGF-β antibodies in dbldb mice

被引:115
作者
Chen, S [1 ]
Igleasias-de la Cruz, MC [1 ]
Jim, B [1 ]
Hong, SW [1 ]
Isono, M [1 ]
Ziyadeh, FN [1 ]
机构
[1] Univ Penn, Dept Med, Penn Ctr Mol Studies Kidney Dis, Renal Electrolyte & Hypertens Div, Philadelphia, PA 19104 USA
关键词
glomerular basement membrane thickening mesangial matrix expansion; type; 2; diabetes; reversal;
D O I
10.1016/S0006-291X(02)02708-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Treatment with a neutralizing anti-transforming growth factor-beta (TGF-beta) antibody can prevent the development of diabetic nephropathy in the db/db mouse, a model of type 2 diabetes, However, it is unknown whether anti-TGF-beta therapy can reverse the histological lesions of diabetic glomerulopathy once they are established. Diabetic db/db mice and their non-diabetic db/m littermates were allowed to grow until 16 weeks of age, by which time the db/db mice had developed glomerular basement membrane (GBM) thickening and mesangial matrix expansion. The mice were then treated with an irrelevant control IgG or a panselective, neutralizing anti-TGF-beta antibody for eight more weeks. Compared with control db/m mice, the dh/dh mice treated with IgG had developed increased GBM width (16.64 +/- 0.80 nm vs. 21.55 +/- 0.78 nm, P < 0.05) and increased mesangial matrix fraction (4.01 +/- 0.81% of total glomerular area vs. 9.55 +/- 1.041,), (P < 0.05). However, the db/db mice treated with anti-TGF-beta antibody showed amelioration of GBM thickening (18.40 +/- 0.72 nm, P < 0.05 vs. db/db-IgG) and mesangial matrix accumulation (6.32 +/- 1.79%, P < 0.05 vs. db/db-IgG). Our results demonstrate that inhibiting renal TGF-beta activity can partially reverse the GBM thickening and mesangial matrix expansion in this mouse model of type 2 diabetes. Anti-TGF-beta regimens would be useful in the treatment of diabetic nephropathy. (C) 2002 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:16 / 22
页数:7
相关论文
共 50 条
[1]  
ABOUNA GM, 1983, LANCET, V2, P1274
[2]  
Baines LA, 2001, DIABETES, V50, P843
[3]   Preserving renal function in adults with hypertension and diabetes: A consensus approach [J].
Bakris, GL ;
Williams, M ;
Dworkin, L ;
Elliott, WJ ;
Epstein, M ;
Toto, R ;
Tuttle, K ;
Douglas, J ;
Hsueh, W ;
Sowers, J .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 36 (03) :646-661
[4]   EARLY GLOMERULOPATHY IS PRESENT IN YOUNG, TYPE-1 (INSULIN-DEPENDENT) DIABETIC-PATIENTS WITH MICROALBUMINURIA [J].
BANGSTAD, HJ ;
OSTERBY, R ;
DAHLJORGENSEN, K ;
BERG, KJ ;
HARTMANN, A ;
NYBERG, G ;
BJORN, SF ;
HANSSEN, KF .
DIABETOLOGIA, 1993, 36 (06) :523-529
[5]   EFFECT OF GLYCEMIC CONTROL ON EARLY DIABETIC RENAL LESIONS - A 5-YEAR RANDOMIZED CONTROLLED CLINICAL-TRIAL OF INSULIN-DEPENDENT DIABETIC KIDNEY-TRANSPLANT RECIPIENTS [J].
BARBOSA, J ;
STEFFES, MW ;
SUTHERLAND, DER ;
CONNETT, JE ;
RAO, KV ;
MAUER, SM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 272 (08) :600-606
[6]   THE EFFECTS OF PANCREAS TRANSPLANTATION ON THE GLOMERULAR STRUCTURE OF RENAL-ALLOGRAFTS IN PATIENTS WITH INSULIN-DEPENDENT DIABETES [J].
BILOUS, RW ;
MAUER, SM ;
SUTHERLAND, DER ;
NAJARIAN, JS ;
GOETZ, FC ;
STEFFES, MW .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (02) :80-85
[7]   PREVENTION OF KIDNEY GRAFT DIABETIC NEPHROPATHY BY PANCREAS TRANSPLANTATION IN MAN [J].
BOHMAN, SO ;
TYDEN, G ;
WILCZEK, H ;
LUNDGREN, G ;
JAREMKO, G ;
GUNNARSSON, R ;
OSTMAN, J ;
GROTH, CG .
DIABETES, 1985, 34 (03) :306-308
[8]   Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy [J].
Brenner, BM ;
Cooper, ME ;
de Zeeuw, D ;
Keane, WF ;
Mitch, WE ;
Parving, HH ;
Remuzzi, G ;
Snapinn, SM ;
Zhang, ZX ;
Shahinfar, S .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) :861-869
[9]   Cellular basis of diabetic nephropathy 1. Study design and renal structural-functional relationships in patients with long-standing type 1 diabetes [J].
Caramori, ML ;
Kim, Y ;
Huang, CM ;
Fish, AJ ;
Rich, SS ;
Miller, ME ;
Russell, G ;
Mauer, M .
DIABETES, 2002, 51 (02) :506-513
[10]   The key role of the transforming growth factor-β system in the pathogenesis of diabetic nephropathy [J].
Chen, S ;
Hong, SW ;
Iglesias-de la Cruz, MC ;
Isono, M ;
Casaretto, A ;
Ziyadeh, FN .
RENAL FAILURE, 2001, 23 (3-4) :471-481